## **Core Concept**
Methicillin-resistant *Staphylococcus aureus* (MRSA) infections are a significant concern due to their resistance to beta-lactam antibiotics, including methicillin. The treatment of MRSA infections requires antibiotics that are effective against this resistant strain. Vancomycin has historically been a mainstay in the treatment of MRSA infections.

## **Why the Correct Answer is Right**
Vancomycin is a glycopeptide antibiotic that inhibits cell wall synthesis in bacteria. It is effective against MRSA because it binds to the D-alanyl-D-alanine terminus of cell wall precursors, preventing their incorporation into the cell wall, which ultimately leads to cell lysis. Vancomycin is bactericidal against MRSA and has been a drug of choice for serious MRSA infections, including skin and soft tissue infections, bacteremia, and endocarditis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not specified, but if it were another antibiotic not effective against MRSA, such as penicillin or ampicillin, it would be incorrect due to MRSA's resistance to these drugs.
- **Option B:** Similarly, without specification, if this option were another antibiotic ineffective against MRSA, such as ceftriaxone (a cephalosporin), it would be incorrect because MRSA is resistant to cephalosporins.
- **Option C:** Without details, if this option represented an antibiotic with limited or no activity against MRSA, it would be incorrect.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that vancomycin-resistant *Enterococcus* (VRE) and some strains of MRSA with reduced susceptibility to vancomycin (VRSA) are emerging, making the management of resistant Gram-positive infections increasingly challenging. Monitoring for resistance patterns is crucial.

## **Correct Answer:** . Vancomycin